sacituzumab govitecan,Pembrolizumab,Avelumab,Zimberelimab,Domvanalimab
Gilead Sciences,Merck,Pfizer,Arcus Biosciences,Otsuka
['muc ,(-much)', 'pembro', 'sacituzumab', 'trophy,u-01', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'sacitu, govi']
primary analysis of #trophy-u-01 cohort 3, a phase 2 study of sacituzumab govitecan in combination with pembro in pts with #muc that progressed after platinum-based therapy. presented by . #gu23 &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology